CHARLOTTE, NC – (BUSINESS THREAD) – cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most trusted and recognized CBD companies, announced today that it has signed a contract extension of its advertising partnership with Spotify (NYSE: SPOT) and the Joe experience Rogan (JRE).
The company announced that the exclusive CBD partnership will continue until 2022 with the podcast heading the charts. JRE, the world’s number one podcast, is one of the most popular and innovative podcasts on the market, giving the company a unique opportunity to reach a large dedicated audience. Signed in 2019, this long-standing partnership is based on the fact that Joe Rogan is a first-time customer and expressed a desire to continue the relationship.
“This partnership is something we wanted to really focus on and extend into the new year. Joe Rogan’s audience is some of the most dedicated listeners and they’ve always welcomed the CBD community with open arms. Like Joe, we’re fans first. “cbdMD and the experience of Joe Rogan are the perfect collaboration between product endorsement and real-life application. We are excited to see where this partnership goes until 2022,” said Martin Sumichrast, co- CEO of cbdMD, Inc.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most trusted and recognized cannabidiol (CBD) brands with a full line of THC1-free CBD products produced in the United States. Currently, the cbdMD brand includes more than 130 SKUs of high quality CBD products, including CBD tinctures, CBD jelly beans, CBD topicals, CBD capsules, CBD bath pumps, CBD bath salts, sleeping pills CBD, CBD beverage blends and full spectrum CBD options. Our brand of Pet Paw CBD products includes over 45 SKUs of products formulated by veterinarians that include tinctures, chews, topical products in different concentrations, and our brand of beauty and skin care products CBD Botanicals includes 15 SKUs , which include facial oil and serum, toners and moisturizers. , fair skin, facial masks, scrubs and body care. The company also offers a full spectrum product line (approximately 10 SKUs) under its cbdMD brand. To learn more about cbdMD and its full line of CBD-free, THC1-free CBD oil products, visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 outlets offering cbdMD products .
Prospective statements
This press release contains certain forward-looking statements that are based on current expectations and that involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by using of words such as ” should ”, ” can, ” ” intend ”, ” anticipate ”, ” believe ”, ” estimate ”, ” projects, ” ” forecasts, ” ” wait ”, ” plan ” and ” propose ”. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. and could cause actual results to differ materially from those expressed or anticipated in the forward-looking statements, including, without limitation, statements made with respect to the expanding consumer market for CBD products, our ability to increase our share market, the availability of the Amazon platform for our CBD products, our ability to expand our business and significantly increase our revenue, our ability to effectively leverage our brand partnerships and sponsorships, our ability to compete effectively in our market, our ability to achieve our net sales orientation and our ability to report profitable operations in the future. . We urge you to carefully review and consider any warnings and other disclosures, including statements made under the heading “Risk Factors” in cbdMD, Inc.’s annual report. on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those of forward-looking statements, many of which are generally beyond the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. assumes no duty to update any forward-looking statements unless required by law. The information that appears on our websites and on our social media platforms, including, among others, Instagram and Facebook, is not part of this press release.
Without 1THC it is defined as below the level of detection by validated scientific methods.
No related posts.
